These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2903922)

  • 1. History of enteric coated sulfasalazine in rheumatoid arthritis.
    Pinals RS
    J Rheumatol Suppl; 1988 Sep; 16():1-4. PubMed ID: 2903922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of rheumatoid arthritis.
    Schinagl EF; Strauss PC
    N Engl J Med; 1996 Sep; 335(11):822; author reply 822-3. PubMed ID: 8778594
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experiences in long-term therapy of rheumatoid arthritis with sulfasalazine tablets].
    Amos RS
    Z Rheumatol; 1987; 46(2):76-8. PubMed ID: 2885988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symposium on enteric-coated sulphasalazine in rheumatoid arthritis. Proceedings of a symposium. London, December 6, 1985.
    Drugs; 1986; 32 Suppl 1():1-80. PubMed ID: 2877848
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of age and acetylator phenotype on the pharmacokinetics of sulfasalazine in patients with rheumatoid arthritis.
    Taggart AJ; McDermott BJ; Roberts SD
    Clin Pharmacokinet; 1992 Oct; 23(4):311-20. PubMed ID: 1356683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A double blind comparative study between salazosulfapyridine enteric coated tablets (PJ-306) and lobenzarit disodium (CCA) in rheumatoid arthritis].
    Nishioka K; Azuma T; Iwasaki Y
    Ryumachi; 1991 Jun; 31(3):346-67. PubMed ID: 1683016
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative systemic availability of sulfapyridine from commercial enteric-coated and uncoated sulfasalazine tablets.
    Pieniaszek HJ; Resetarits DE; Wilferth WW; Blumenthal HP; Bates TR
    J Clin Pharmacol; 1979 Jan; 19(1):39-45. PubMed ID: 33201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphasalazine and inflammatory bowel disease.
    Chapman P
    N Z Med J; 1987 Apr; 100(822):257. PubMed ID: 2901061
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of salazosulfapyridine enteric-coated capsules in therapy of rheumatoid arthritis].
    Suzuki T; Sugawara S; Yoshizawa H; Koshino T; Tanaka K
    Ryumachi; 1988 Dec; 28(6):466-7. PubMed ID: 2907950
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparisons of sulfasalazine to gold and placebo in the treatment of rheumatoid arthritis.
    Williams HJ
    J Rheumatol Suppl; 1988 Sep; 16():9-13. PubMed ID: 2903928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of responses to and adverse effects of graded doses of sulfasalazine in the treatment of rheumatoid arthritis.
    Skosey JL
    J Rheumatol Suppl; 1988 Sep; 16():5-8. PubMed ID: 2903927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfasalazine: I. An historical perspective.
    Bachrach WH
    Am J Gastroenterol; 1988 May; 83(5):487-96. PubMed ID: 2896458
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial.
    O'Dell JR; Leff R; Paulsen G; Haire C; Mallek J; Eckhoff PJ; Fernandez A; Blakely K; Wees S; Stoner J; Hadley S; Felt J; Palmer W; Waytz P; Churchill M; Klassen L; Moore G
    Arthritis Rheum; 2002 May; 46(5):1164-70. PubMed ID: 12115219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination therapy in early rheumatoid arthritis: the COBRA study].
    Boers M; Verhoeven AC; van der Linden S
    Ned Tijdschr Geneeskd; 1997 Dec; 141(50):2428-32. PubMed ID: 9555126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enteric-coated phenylbutazone in the treatment of rheumatic conditions in patients prone to gastric irritation (author's transl)].
    Mauracher EH
    Schweiz Rundsch Med Prax; 1975 Dec; 64(51):1644-7. PubMed ID: 765998
    [No Abstract]   [Full Text] [Related]  

  • 16. [Methotrexate and salazosulfapyridine in the long-term treatment of rheumatoid arthritis].
    Ichikawa Y; Shinozawa T; Yoshida T; Kameda H; Suzuki Y; Kawai S; Yamada H; Matsuda T
    Ryumachi; 1995 Aug; 35(4):663-70. PubMed ID: 7482063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
    Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
    Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
    Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R;
    J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
    Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
    J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.
    Shiroky JB
    J Rheumatol Suppl; 1996 Mar; 44():69-71. PubMed ID: 8833057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.